colab
  • home
  • what we do
  • impact
  • reports
  • collaborate
    • colab releases
  • COVID 19
  • blog
Select Page

Project Orbis. Accelerating time to patient access?

Mar 7, 2023 | access, health policy, oncology, oncopolicy | 0 comments

Timely access to innovative treatments is crucial for those living with cancer. However, for Candians with cancer, the approval process for such treatments can be lengthy and complex. Cancer treatments usually receive Health Canada and subsequent health technology...

Canadians with cancer are asking “where is cancer?” in the proposed healthcare plan announced yesterday

Feb 8, 2023 | health policy, oncology, oncopolicy | 0 comments

PROVIDED BY Cancer Action Now  TORONTO, Feb. 8, 2023 /CNW/ – As the Prime Minister and Premiers convened in Ottawa yesterday to discuss much-needed reforms to Canada’s health systems, cancer patients and stakeholder groups...

open letter: let’s put cancer at the top of the agenda

Nov 7, 2022 | access, health policy, oncology, oncopolicy | 0 comments

as the ministers of health across the country meet in vancouver over the next couple of days, the CANCER ACTION NOW ALLIANCE members have drafted a letter to remind them of the canadians, who every day are diagnosed, treated, screened and die from cancer. an ongoing...
understanding biomarkers

understanding biomarkers

Nov 3, 2021 | biomarkers, health policy, innovation, oncology, precision medicine | 0 comments

because we know that cancer can be highly variable from one person to the other, based on the changes at the molecular level, each patient, even those with the same diagnosis, have a unique set of changes that influence how a person will respond to therapy, or how...

improving access to innovative therapies

Nov 17, 2020 | biosimilars, innovation, oncology | 0 comments

here’s how biologics have become an important part in the cancer landscape, providing better outcomes for some patients . because they are made from living organisms biologics can not be exactly copied [generics]. the complex manufacturing process of biologics...

ASCO 20 – UNITE AND CONQUER TO ACCELERATE PROGRESS TOGETHER

Jun 23, 2020 | #travelwithcolab, asco, innovation, oncology | 0 comments

for the first time since its inception in 1965, the ASCO scientific conference was held virtually amid the COVID 19 pandemic. this did not stop the global oncology community from convening during three days [from may 29-31] to accelerate progress together. on june 4th...
« Older Entries
  • understanding cancer
  • what is precision medicine
  • what is precision medicine awareness month
  • personalized versus precision medicine
  • genetics vs genomics
  • what are biomarkers
  • molecular profiling
  • Twitter
  • Instagram
  • Linkedin